Skip to main content
Equibles

PROFUND ADVISORS LLC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1129919 BETHESDA, MD
Back to TMO Full portfolio

Position in TMO

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$2,074,627
+$10,693 QoQ
Shares Held
4,138
-1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,163
of 2,620 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $15,038,497 across 17 Diagnostics & Research names. TMO ranks #2 (13.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IDXX
Idexx Laboratories Inc /De
 6,365 $3,350,790
2 TMO
Thermo Fisher Scientific Inc.
This page 		4,138 $2,074,627
3 NTRA
Natera, Inc.
 6,205 $1,684,347
4 VCYT
Veracyte, Inc.
 24,694 $1,450,278
5 GRAL
GRAIL, Inc.
 20,078 $1,370,725
6 DHR
Danaher Corp /De/
 7,015 $1,336,217
7 ILMN
Illumina, Inc.
 3,154 $554,567
8 CDNA
CareDx, Inc.
 16,518 $470,763

All Filings in TMO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,074,627 4,138
2026-03-31 $2,063,934 4,199
2025-12-31 $3,542,177 6,113
2025-09-30 $2,365,442 4,877
2025-06-30 $1,954,722 4,821
2025-03-31 $2,605,433 5,236
2024-12-31 $2,801,438 5,385
2024-09-30 $3,793,689 6,133
2024-06-30 $3,288,138 5,946
2024-03-31 $3,516,901 6,051
2023-12-31 $3,360,962 6,332
2023-09-30 $3,025,378 5,977
2023-06-30 $3,207,197 6,147
2023-03-31 $3,515,857 6,100
2022-12-31 $3,388,946 6,154
2022-09-30 $3,173,487 6,257
2022-06-30 $3,572,066 6,575
2022-03-31 $4,474,173 7,575
2021-12-31 $6,095,237 9,135
2021-09-30 $4,763,749 8,338
2021-06-30 $4,098,818 8,125
2021-03-31 $3,670,207 8,042
2020-12-31 $4,321,041 9,277
2020-09-30 $4,156,469 9,414
2020-06-30 $4,279,235 11,810
2020-03-31 $2,648,540 9,339